We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appellate Court Upholds Dismissal of Mylan Antitrust Suit Against Doryx Drugmakers
Appellate Court Upholds Dismissal of Mylan Antitrust Suit Against Doryx Drugmakers
A federal appellate court upheld a district court dismissal of Mylan’s antitrust case against Warner Chilcott and Mayne Pharmaceuticals, which alleged that the name-brand drugmakers modified their acne treatment Doryx to maintain a monopoly on the market.